First-in-human trial of VBC106 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called VBC106 for people with advanced solid tumors that have not responded to other treatments. It is the first time this drug is being tested in humans, and aims to see if it is safe and helps shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have an advanced solid tumor that has grown or returned after standard treatments, or standard treatments are not safe or appropriate for you.
- You must have at least one tumor that can be measured on a scan (like a CT or MRI).
- You must be feeling fairly well and able to do daily activities (performance status 0 or 1).
- You must have normal heart and lung function, and no recent serious heart problems or untreated brain metastases.
- You must be able to provide a tumor sample (either from a previous biopsy or a new one).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, VBC103, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink or slow the growth of these tumors.
This trial tests a new drug called VBC101 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if VBC101 is safe and effective.
This trial tests an experimental drug called VBC108 in people with advanced solid tumors that have not responded to other treatments. The study aims to see if the drug is safe and effective.
This trial tests a new drug for people with advanced solid tumors that have spread or can't be removed. The drug targets specific proteins on cancer cells to try to shrink or slow the cancer.
This trial tests a new drug called GB268, which targets three different proteins (PD-1, CTLA-4, and VEGF) that help tumors grow and hide from the immune system. It is for people with advanced solid tumors who have tried standard treatments, or for whom no standard treatment is available.
This trial tests a new drug, BHV-1510, alone or combined with another drug (cemiplimab), for people with advanced solid tumors that haven't responded to other treatments. It's for those who are still in fairly good health and have not had certain prior treatments.
Hear when a new Participants With Advanced Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.